UTMD icon

Utah Medical Products
UTMD

Overview Fund Activity

78 hedge funds and large institutions have $216M invested in Utah Medical Products in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 4 closing their positions.

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
23
Reduced
31
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$3.5M
2
Russell Investments Group
2
Russell Investments Group
United Kingdom
$6.12M
3
WAM
3
Watershed Asset Management
California
$243K
4
Citadel Advisors
4
Citadel Advisors
Florida
$214K
5
Invesco
5
Invesco
Georgia
$201K

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.96M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$7.89M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$18.5M
4
Loomis, Sayles & Company
4
Loomis, Sayles & Company
Massachusetts
$4.51M
5
AQR Capital Management
5
AQR Capital Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CS
76
Credit Suisse
Switzerland
$1K +$529 +9 +113%
C
77
Covestor
United Kingdom
$1K +$1K +16 New
AQR Capital Management
78
AQR Capital Management
Connecticut
– -$459K -5,346 Closed
UBS Group
79
UBS Group
Switzerland
– -$34K -391 Closed
UBS AM
80
UBS AM
Illinois
– -$3.78K -44 Closed
Rockefeller Capital Management
81
Rockefeller Capital Management
New York
– -$3K -35 Closed
1 2 3
4